Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome

Published:2020-04-01 Issue:4 Volume:6 Page:486
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Atallah Ehab¹,Logan Brent²,Chen Min³,Cutler Corey⁴,Deeg Joachim⁵,Jacoby Meagan⁶,Champlin Richard⁷,Nishihori Taiga⁸,Confer Dennis⁹,Gajewski James¹⁰¹¹,Farnia Stephanie⁹,Greenberg Peter¹²,Warlick Erica¹³,Weisdorf Daniel¹³,Saber Wael³,Horowitz Mary M.³,Rizzo J. Douglas³

Affiliation:

1. Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee

2. Division of Biostatistics, Department of Institute for Health and Equity, Medical College of Wisconsin, Milwaukee

3. Center for International Bone Marrow Transplant Research, Medical College of Wisconsin, Milwaukee

4. Dana-Farber Cancer Institute, Boston, Massachusetts

5. Fred Hutchinson Cancer Research Center, Seattle, Washington

6. Washington University School of Medicine in St Louis, St Louis, Missouri

7. Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas

8. Moffitt Cancer Center, University of South Florida, Tampa

9. National Marrow Donor Program, Minneapolis, Minnesota

10. Lu Daopei Hospitals, Beijing

11. Oregon Society of Medical Oncology, Portland

12. Stanford University School of Medicine, Stanford, California

13. University of Minnesota, Minneapolis

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2757386/jamaoncology_atallah_2019_oi_190096.pdf

Reference24 articles.

1. Myelodysplastic syndromes: incidence and survival in the United States.;Ma;Cancer,2007

2. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.;McClune;J Clin Oncol,2010

3. What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?;Appelbaum;Best Pract Res Clin Haematol,2008

4. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).;Estey;Blood,2007

5. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.;Rowlings;Br J Haematol,1997

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

2. Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102;JCO Oncology Practice;2024-01-23

3. Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Patients;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Clinical decision-making and treatment of myelodysplastic syndromes;Blood;2023-12-28

5. Allogreffe dans les syndromes myélodysplasiques;Bulletin du Cancer;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3